Article
Newborn screening for primary carnitine deficiency using a second-tier genetic test.
Journal of pediatric endocrinology & metabolism : JPEM - 26 Feb 2024
Lin Yiming, Lin Chunmei, Zheng Zhenzhu, Huang Chenggang, Peng Weilin
Abstract excerpt
OBJECTIVES: Newborn screening (NBS) for primary carnitine deficiency (PCD) exhibits suboptimal performance. This study proposes a strategy to enhance the efficacy of second-tier genetic screening by adjusting the cutoff value for free carnitine (C0). METHODS: Between January 2021 and December 2022, we screened 119,898 neonates for inborn metabolic disorders. Neonates with C0 levels below 12 μmol/L were randomly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
